Signals
New global heart failure definition exposes a policy gap: systems still diagnose too late and treat too narrowly
Global cardiovascular societies have released the Second Universal Definition of Heart Failure, shifting the field away from rigid ejection fraction thresholds and toward earlier detection, disease trajectory, underlying causes and global equity. The science is moving from “heart failure as a fixed diagnosis” to “heart failure as a dynamic, preventable and heterogeneous condition.”
AI Pathology Starts Moving Toward Treatment Selection
Hepatitis B Functional Cure Moves Closer, But Access Still Starts With Diagnosis
A Urine Test for Alzheimer’s Would Change the Access Conversation
AI Multiomics Moves Into the Trial Stratification Layer
IAPM Launches Oncology Pillar at ASCO: Closing the Gap Between Cancer Breakthroughs and Patient Access
WHA 2026: WHO resolution moves precision medicine onto the global health policy agenda
ASCO 2026: Pancreatic cancer gets its precision medicine moment
ASCO 2026: GI cancers are finally moving out of oncology’s blind spot
ASCO 2026: AI is entering cancer care before the rules are ready
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.